Multidimensional molecular changes-environment interaction analysis for disease outcomes

Yaqing Xu, Mengyun Wu, Shuangge MaarXiv 2019 · DOI · arXiv

Introduction

The etiology of complex diseases—ranging from cancer to cardiovascular disorders—is rarely attributable to a single genetic or environmental factor. Instead, these conditions emerge from a sophisticated "dialogue" between an individual's multidimensional biological landscape and external environmental exposures. While modern high-throughput technologies allow for the simultaneous measurement of various molecular layers—such as gene expression (mRNA), copy number variations (CNV), and DNA methylation—integrating these data types into a cohesive predictive model remains a significant challenge.

Traditional analyses often examine a single molecular layer in isolation or treat multiple layers as independent variables. This approach overlooks two critical biological realities:

  1. Information Overlap: Molecular layers are intrinsically linked through regulatory mechanisms; for instance, a CNV may directly influence the expression levels of specific genes.
  2. Biological Hierarchy: Interactions between molecular factors and the environment typically follow a hierarchical structure where the interaction effect is often contingent upon the presence of a significant main effect.

This paper introduces a novel "M-E interaction analysis" framework designed to accommodate multidimensional molecular changes (M) and environmental risk factors (E), accounting for both overlapping regulatory information and independent biological signals.

The M-E Interaction Framework

The proposed methodology utilizes a three-step pipeline grounded in penalization techniques and hierarchical modeling.

Step 1: Identifying Regulatory Modules

The first stage involves identifying "regulatory modules"—coordinated groups of genes and their specific regulators (e.g., CNVs or methylation sites). By employing penalized regression (Lasso) and specialized biclustering techniques, the framework maps the regulatory relationships between different molecular layers. This step ensures that the model reflects the actual biological flow of information rather than treating data as a flat, unstructured list.

Step 2: Information Integration and Dimension Reduction

To manage the high dimensionality of omics data and reduce noise, the authors apply Principal Component Analysis (PCA) within the identified modules. Unlike standard PCA applied to an entire dataset, this targeted approach collapses complex groups of variables into a few "Principal Components" that capture at least 80% of the shared information. This preserves the biological context of the interactions while effectively mitigating collinearity.

Step 3: Joint Hierarchical Modeling

The final step involves a joint regression model that incorporates environmental factors, the molecular modules, and individual molecular units. The framework utilizes a Group Lasso penalty to enforce a "strong heredity" constraint. Under this constraint, an interaction between a molecular factor and an environmental variable is only considered for inclusion if the main effect of that molecular factor is also found to be significant. This statistical rigor ensures that the identified interactions are biologically plausible and statistically sound.

Experimental Validation

The framework was rigorously tested through both extensive simulations and the analysis of real-world cancer datasets from The Cancer Genome Atlas (TCGA).

Simulation Studies

In various simulation scenarios featuring different regulation patterns and correlation structures, the M-E interaction analysis consistently outperformed alternative methods. It achieved higher True Positive (TP) rates and lower False Positive (FP) rates, demonstrating a superior ability to distinguish true biological signals from background noise.

Case Study: Lung Adenocarcinoma (LUAD)

The model was applied to data from 164 subjects to predict lung capacity (FEV1) using mRNA expression, CNV, and DNA methylation data. The M-E framework identified 62 main molecular effects and 29 environment interactions. Notably, it demonstrated exceptional Selection Stability, achieving an Observed Occurrence Index (OOI) of 0.77, significantly higher than the 0.53 achieved by the best-performing alternative method.

Case Study: Cutaneous Melanoma (SKCM)

In an analysis of survival data for 231 subjects, the method outperformed traditional models in predictive accuracy, yielding a C-statistic of 0.60. The analysis identified several biologically significant markers, including the IMP3 gene, which is associated with cell proliferation, and IL24, a known tumor suppressor.

Discussion and Key Insights

The success of the M-E interaction analysis highlights the importance of incorporating biological hierarchy into statistical models. By prioritizing Selection Stability over simple sensitivity, the framework identifies markers that are more likely to remain consistent across different patient cohorts. Furthermore, the targeted use of PCA within regulatory modules demonstrates that dimensionality reduction is most effective when it respects the underlying biological structure.

Conclusion and Future Directions

The M-E interaction framework provides a robust statistical ground for analyzing how multidimensional molecular changes interact with environmental factors to influence disease outcomes. While the current model is optimized for gene expression and its regulators, future work may extend this approach to include other "multi-omics" layers such as proteomics and metabolomics. Additionally, exploring alternative dimension reduction techniques like Partial Least Squares (PLS) could further refine the model's predictive power.

Summary updated

Abstract

For the outcomes and phenotypes of complex diseases, multiple types of molecular (genetic, genomic, epigenetic, etc.) changes, environmental risk factors, and their interactions have been found to have important contributions. In each of the existing studies, only the interactions between one type of molecular changes and environmental risk factors have been analyzed. In recent biomedical studies, multidimensional profiling, under which data on multiple types of molecular changes is collected on the same subjects, is becoming popular. A myriad of recent studies have shown that collectively analyzing multiple types of molecular changes is not only biologically sensible but also leads to improved estimation and prediction. In this study, we conduct M-E interaction analysis, with M standing for multidimensional molecular changes and E standing for environmental risk factors, which can accommodate multiple types of molecular measurements and sufficiently account for their overlapping information (attributable to regulations) as well as independent information. The proposed approach is based on the penalization technique, has a solid statistical ground, and can be effectively realized. Extensive simulation shows that it outperforms multiple closely relevant alternatives. In the analysis of TCGA (The Cancer Genome Atlas) data on lung adenocarcinoma and cutaneous melanoma, sensible findings with superior stability and prediction are made.
BibTeX
@misc{xu2019multidimensional,
  author = {Yaqing Xu and Mengyun Wu and Shuangge Ma},
  title = {{Multidimensional molecular changes-environment interaction analysis for disease outcomes}},
  year = {2019},
  eprint = {1912.08370},
  archivePrefix = {arXiv},
  url = {https://arxiv.org/abs/1912.08370},
}
Figure